Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 196 AL 210

Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials

Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):6014-21. doi: 10.2174/1381612820666140316130720.

Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study

Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.

J Alzheimers Dis. 2014;41(2):633-40. doi: 10.3233/JAD-132735.

Cardiopulmonary exercise testing is well tolerated in people with Alzheimer-related cognitive impairment

Billinger SA, Vidoni ED, Greer CS, Graves RS, Mattlage AE, Burns JM.

Arch Phys Med Rehabil. 2014 Sep;95(9):1714-8. doi: 10.1016/j.apmr.2014.04.007. Epub 2014 Apr 26.

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K.

Expert Opin Drug Saf. 2014 Jun;13(6):759-74. doi: 10.1517/14740338.2014.914168.

Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease

Yarchoan M, Arnold SE.

Diabetes. 2014 Jul;63(7):2253-61. doi: 10.2337/db14-0287. Epub 2014 Jun 15.

Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective

Apetz N, Munch G, Govindaraghavan S, Gyengesi E.

CNS Neurol Disord Drug Targets. 2014;13(7):1175-91. doi: 10.2174/1871527313666140917110635.

The role of gastrostomy tube placement in advanced dementia with dysphagia: a critical review

Goldberg LS, Altman KW.

Clin Interv Aging. 2014 Oct 14;9:1733-9. doi: 10.2147/CIA.S53153. eCollection 2014.

A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease

Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J.

J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722.

Art therapy for Alzheimer's disease and other dementias

Chancellor B, Duncan A, Chatterjee A.

J Alzheimers Dis. 2014;39(1):1-11. doi: 10.3233/JAD-131295.

The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease

Ohnishi T, Sakiyama Y, Okuri Y, Kimura Y, Sugiyama N, Saito T, Takahashi M, Kobayashi T.

Curr Alzheimer Res. 2014 Feb;11(2):110-8. doi: 10.2174/15672050113106660167.

Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2

Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2014 Jan;22(1):14-24. doi: 10.1016/j.jagp.2013.02.014.

[The influence of long-term care on the health of caregivers of Alzheimer's disease patients]

Rachel W, Datka W, Zyss T, Zięba A.

Przegl Lek. 2014;71(12):703-6.

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT.

Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7.

Open-label, short-term, repetitive transcranial magnetic stimulation in patients with Alzheimer's disease with functional imaging correlates and literature review

Devi G, Voss HU, Levine D, Abrassart D, Heier L, Halper J, Martin L, Lowe S.

Am J Alzheimers Dis Other Demen. 2014 May;29(3):248-55. doi: 10.1177/1533317513517047. Epub 2014 Jan 13.

[Long-term antipsychotics for patients with dementia - discontinue or continue treatment?]

Renard D, de Pélichy E, von Elm E.

Praxis (Bern 1994). 2014 Jan 15;103(2):109-10. doi: 10.1024/1661-8157/a001543.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias